Veterinary Anesthetic Alfaxan Approved for U.S. Distribution

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs.


Published:

Each milliliter of Alfaxan contains 10 milligrams of the active ingredient alfaxalone.

An intravenous injectable anesthetic commonly used in Australia will be released to U.S. veterinarians Aug. 25, the manufacturer, Jurox Animal Health, reported.

Alfaxan (alfaxalone 10 mg/mL) is approved for use in cats and dogs. The drug is indicated for the induction and maintenance of anesthesia and for the induction of anesthesia followed by maintenance with an inhalant anesthetic.

Winning U.S. Food and Drug Administration approval of Alfaxan took time, said JJ O’Brien, CEO of Australia-based Jurox.

“Since beginning this process, we have had countless inquiries as to why it has not been available to U.S. veterinarians,” O’Brien said.

The drug is widely accepted by Australian veterinarians and has been used in 20 countries.

“An independent study commissioned by Jurox reported Australian veterinarians to rely on Alfaxan for induction as often as 74 percent of the time in cats and 52 percent in dogs,” the company stated.

Alfaxan’s U.S. distributors will include Henry Schein Animal Health, MWI Veterinary Supply, Patterson Veterinary Supply, NEVSCo, Midwest Veterinary Supply and Victor Medical Co.

Jurox earlier this summer opened its U.S. headquarters in Kansas City, Mo.

Edit Module
Edit ModuleShow Tags

Archive »Read More

St. George’s University Forms Partnership with Canadian College

The partnership opens a pathway for prospective veterinarians at St. Lawrence College to join St. George’s University’s veterinary medical program.

There's More Options for Bad Joints in Aging Pets

Veterinarians discuss they're preferred treatments.

Open Letter to AVMA Board Chairman Chip Price and Responses, March 2015 Letters

The March 2015 issue of Veterinary Practice News presented an open letter from four noted veterinary professionals to AVMA board of directors chairman Chip Price along with responses from Dr. Price and from Western and Lincoln Memorial universities, which the open letter references.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module